HAYWARD, Calif.--(BUSINESS WIRE)--Jan. 31, 2007--IMPAX
Laboratories, Inc. (OTC: IPXL) today announced that management will
present at the Merrill Lynch Global Pharmaceutical, Biotechnology and
Medical Device Conference on Wednesday, February 7, 2007 at 11:40 a.m.
Eastern Time. The conference will be held on February 6-8, 2007 at the
Grand Hyatt Hotel in New York City.
Individuals may listen to the live and archived presentation,
which will be posted in the investor relations section of the
Company's web site at www.impaxlabs.com. To listen to the live
presentation, please go to the web site 15 minutes prior to its start
to register, download, and install the necessary audio software. The
presentation will be archived on the Company's web site for 14 days.
About IMPAX Laboratories, Inc.
IMPAX Laboratories, Inc. is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded products.
IMPAX markets its generic products through its Global Pharmaceuticals
division and markets its branded products through the IMPAX
Pharmaceuticals division. Additionally, where strategically
appropriate, IMPAX has developed marketing partnerships to fully
leverage its technology platform. IMPAX Laboratories is headquartered
in Hayward, California, and has a full range of capabilities in its
Hayward and Philadelphia facilities. For more information, please
visit the Company's Web site at: www.impaxlabs.com.
CONTACT: Company Contacts:
IMPAX Laboratories, Inc.
Larry Hsu, Ph.D. President & CEO
510-476-2000, Ext. 1111
or
Arthur Koch, CFO,
215-933-0351
www.impaxlabs.com
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz,
212-838-3777
kgolodetz@lhai.com
or
Bruce Voss,
310-691-7100
bvoss@lhai.com
www.lhai.com
SOURCE: IMPAX Laboratories, Inc.